Drug product and fill finish capabilities:
Whilst applying a broad array of high-throughput technologies, we provide rapid formulation development accompanied by simultaneous real-time and accelerated stability testing according to ICH standards.Formulation development
Polpharma Biologics operates a state-of-the-art biopharmaceutical cGMP drug product manufacturing and fill finish plant. The facility is equipped with disposable liquid filling technologies and lyophilization capabilities, and is run by highly qualified and experienced personnel.Drug product manufacturing
Polpharma Biologics method development, qualification and validation for late stage development define the robust control strategy required to manufacture and commercialize biologic molecules.Analytical development & QC services
All the component to take your product from DNA, through IND and clinical trials and to support your global commercial supply. This includes antibody discovery, cell line development, process development and cGMP manufacturing supported by extensive analytical capabilities.
State of the art microbial manufacturing facilities for fermentation recovery & purification development through to cGMP manufacturing for preclinical, clinical and commercial supply.
Comprehensive biosimilar development capabilities from cell line development to commercial supply to help our partners provide patients access to the most advanced therapies available.